ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 128,32
0,45%
Dow Jones
39 671,04
0,00%
DAX
18 735,60
0,29%
Brent Oil
82,635
1,36%
Bitcoin
69 325,01
0,32%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Relmada Therapeutics Inc (RLMD)

  7. Relmada Therapeutics Inc (RLMD) Actualités

RLMD

Relmada Therapeutics (RLMD)

Relmada Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RLMD
DateHeureSourceTitreSymboleSociété
08/05/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLMDRelmada Therapeutics Inc
19/03/202412h27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:RLMDRelmada Therapeutics Inc
20/02/202423h55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
14/02/202414h53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RLMDRelmada Therapeutics Inc
01/02/202400h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLMDRelmada Therapeutics Inc
11/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLMDRelmada Therapeutics Inc
21/06/202323h01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RLMDRelmada Therapeutics Inc
30/05/202323h11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RLMDRelmada Therapeutics Inc
25/05/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RLMDRelmada Therapeutics Inc
12/05/202311h45PR Newswire (US)RLMD FRAUD ALERT: Jakubowitz Law is Investigating Relmada Therapeutics, Inc. in Connection with Potential Violations of Federal Securities LawsNASDAQ:RLMDRelmada Therapeutics Inc
10/05/202311h45PR Newswire (US)INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Relmada Therapeutics, Inc. of an Investigation and Potential Class Action Lawsuit - (NYSE: RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
31/03/202315h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RLMDRelmada Therapeutics Inc
14/02/202323h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RLMDRelmada Therapeutics Inc
09/02/202317h47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RLMDRelmada Therapeutics Inc
02/02/202323h02Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:RLMDRelmada Therapeutics Inc
08/12/202204h15TipRanksMizuho Securities Sticks to Their Buy Rating for Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
11/11/202212h55TipRanksRelmada Therapeutics (RLMD) Gets a Buy from Mizuho SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
10/11/202222h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RLMDRelmada Therapeutics Inc
17/10/202206h51TipRanksAnalysts’ Top Healthcare Picks: InMode (INMD), Avidity Biosciences (RNA)NASDAQ:RLMDRelmada Therapeutics Inc
13/10/202218h36TipRanksRelmada Nosedives after Depression Therapy Fails in Phase 3NASDAQ:RLMDRelmada Therapeutics Inc
13/10/202213h45TipRanksMizuho Securities Keeps Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
07/10/202219h55TipRanksRelmada Therapeutics put volume heavy and directionally bearishNASDAQ:RLMDRelmada Therapeutics Inc
16/08/202210h45TipRanksSVB Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
09/08/202215h21Dow Jones NewsRelmada Gets FDA Fast-Track Designation for REL-1017 as MDD MonotherapyNASDAQ:RLMDRelmada Therapeutics Inc
09/05/202202h45TipRanksMizuho Securities Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD)NASDAQ:RLMDRelmada Therapeutics Inc
08/05/202217h11TipRanksRelmada Therapeutics (RLMD) Gets a Buy Rating from SVB SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
07/04/202223h14Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:RLMDRelmada Therapeutics Inc
29/03/202202h36TipRanksRelmada Therapeutics (RLMD) Gets a Buy Rating from Mizuho SecuritiesNASDAQ:RLMDRelmada Therapeutics Inc
25/03/202212h54Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RLMDRelmada Therapeutics Inc
29/12/202115h36TipRanksAnalysts’ Top Healthcare Picks: LHC Group (LHCG), BridgeBio Pharma (BBIO)NASDAQ:RLMDRelmada Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RLMD

Dernières Valeurs Consultées

NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
NASDAQ
AAPL
Apple
EU
AF
Air FranceKLM
NYSE
DIS
Walt Disney
EU
HO
Thales
EU
ACA
Credit Agricole
NASDAQ
MSFT
Microsoft
COIN
BTCUSD
Bitcoin
EU
BN
Danone
FTSE
UKX
FTSE 100
EU
RI
Pernod Ricard
NYSE
NKE
Nike
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés